The unprecedented outbreak of COVID-19 across the globe has resulted in increased demand for telemedicine solutions. Social distancing and lockdown implementation by several countries as a preventive measure to curb the pandemic. The impact of COVID 19 led us to explore with six distinguished panelists - Is Telemedicine is the future of Healthcare?
Prof. Myra White, Lecturer on Psychiatry, Harvard Medical School
Greg Jarzabek, Co-Founder, CEO at Trustedoctor
Hassaan Ebrahim, Co-Founder, CEO at Hikma Health
Debbi Gillotti, COO at nVoq, Inc., Board Director at UP
Chad Hiner, RN, VP, Customer Experience at nVoq, Inc
Michael Hatzakis Jr, MD, Owner at HatzakisMD
Roger Hackett, Founder Ryan and Robbie LLC
Mahenoor Yusuf, Co-Chair Harvard in Tech Seattle
1. Telemedicine Technology combines hardware diagnostics, software platforms, and Medical Practice guidance & services. The menu of services possible is expansive, and COVID 19 demonstrates the need to expedite availability.
2. Telemedicine has global reach that can restructure the supply and demand for healthcare.
3. The Rural Urban Divide, and the low income vs. high income divide can be addressed through hybrid offerings via extended reach in the USA and overseas. Regulation and policy across states, and across borders needs to be streamlined and optimized for shared value.
4. Telemedicine can provide a cost effective alternative to cover many existing gaps in the current medical system. These include follow up medical treatment, clarification, diagnostics, and maintenance of care e.g. remedial exercises, and medication adherence.
5. Telemedicine is powerful, and the privacy, governance, and innovation mindset are important to establish Social acceptance.
6. Telemedicine is the future of medicine, and it is critical that all stakeholders are at the table to make sure it is the right future.